What Are the Penalties for Non-Compliance with China DMF Regulations?

Non-compliance with China’s Drug Master File (DMF) regulations can result in severe penalties, including fines, suspension of product registration, and revocation of manufacturing licenses. Companies may face import bans and reputational damage, hindering market access. Ensuring compliance is crucial to maintaining business operations and avoiding legal and financial repercussions.

Leave a Reply

You must be logged in to post a comment.